Oral administration of recombinant cholera toxin subunit B inhibits IL-12 mediated murine experimental colitis.

被引：0
|
作者：
Boirivant, M
Fuss, IJ
Ferroni, L
De Pascale, M
Strober, W
机构：
[1] Inst Super Sanita, Rome, Italy
[2] NIH, Lci, Mis, Bethesda, MD 20892 USA
[3] ISS, Immunol Lab, Rome, Italy
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)84420-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2982
引用
收藏
页码：A571 / A571
页数：1
相关论文
共 50 条
  • [1] Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis
    Boirivant, M
    Fuss, IJ
    Ferroni, L
    De Pascale, M
    Strober, W
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05): : 3522 - 3532
  • [2] Cholera toxin subunit B inhibits IL-12 and IFN-γ production and signaling in experimental colitis and Crohn's disease
    Coccia, EM
    Remoli, ME
    Di Giacinto, C
    Del Zotto, B
    Giacomini, E
    Monteleone, G
    Boirivant, M
    [J]. GUT, 2005, 54 (11) : 1558 - 1564
  • [3] Oral administration of a recombinant cholera toxin B subunit promotes mucosal healing in the colon
    Baldauf, K. J.
    Royal, J. M.
    Kouokam, J. C.
    Haribabu, B.
    Jala, V. R.
    Yaddanapudi, K.
    Hamorsky, K. T.
    Dryden, G. W.
    Matoba, N.
    [J]. MUCOSAL IMMUNOLOGY, 2017, 10 (04) : 887 - 900
  • [4] TREATMENT OF EXPERIMENTAL SLE WITH RECOMBINANT MURINE IL-12
    MITTLEMAN, BB
    SHEARER, GM
    PAYNE, S
    WOLF, S
    MOZES, E
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 883 - 883
  • [5] Repeated Oral Administration of a KDEL-Tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis despite a Robust Immunogenic Response
    Royal, Joshua M.
    Reeves, Micaela A.
    Matoba, Nobuyuki
    [J]. TOXINS, 2019, 11 (12)
  • [6] Effects of recombinant cholera toxin B subunit on IL-β production by macrophages in in vitro
    Maeyama, J
    Isaka, M
    Yasuda, Y
    Matano, K
    Taniguchi, T
    Morokuma, K
    Ohkuma, K
    Tochikubo, K
    Goto, N
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 2002, 46 (09) : 593 - 599
  • [7] RECOMBINANT CHOLERA TOXIN-B SUBUNIT AND GENE FUSION PROTEINS FOR ORAL VACCINATION
    SANCHEZ, J
    JOHANSSON, S
    LOWENADLER, B
    SVENNERHOLM, AM
    HOLMGREN, J
    [J]. RESEARCH IN MICROBIOLOGY, 1990, 141 (7-8) : 971 - 979
  • [8] Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit
    Kubota, E
    Joh, T
    Tanida, S
    Sasaki, M
    Kataoka, H
    Watanabe, K
    Itoh, K
    Oshima, T
    Ogasawara, N
    Togawa, S
    Wada, T
    Yamada, T
    Mori, Y
    Fujita, F
    Shimura, T
    Ohara, H
    Isaka, M
    Yasuda, Y
    Itoh, M
    [J]. HELICOBACTER, 2005, 10 (04) : 345 - 352
  • [9] TOXICOLOGICAL FINDINGS OF A RECOMBINANT CHOLERA TOXIN B SUBUNIT VARIANT WITH THERAPEUTIC POTENTIAL IN ULCERATIVE COLITIS
    Reeves, Micaela
    Tuse, Daniel
    Hamorsky, Krystal
    Royal, Joshua
    Matoba, Nobuyuki
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 : S4 - S4
  • [10] TOXICOLOGICAL FINDINGS OF A RECOMBINANT CHOLERA TOXIN B SUBUNIT VARIANT WITH THERAPEUTIC POTENTIAL IN ULCERATIVE COLITIS
    Reeves, Micaela
    Tuse, Daniel
    Hamorsky, Krystal
    Royal, Joshua
    Matoba, Nobuyuki
    [J]. GASTROENTEROLOGY, 2021, 160 (03) : S6 - S6
12345